828834554	828834554	CD	B-NP	O
|	|	NN	I-NP	O
CVH	CVH	NN	I-NP	O
|	|	NN	I-NP	O
69046457	69046457	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8336825	8336825	CD	B-NP	O
|	|	CC	I-NP	O
7/14/2005	7/14/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Atrial	Atrial	JJ	I-NP	I-protein
fibrilation	fibrilation	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/4/2005	4/4/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/3/2005	10/3/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
EASTRIDGE	EASTRIDGE	NNP	B-NP	O
,	,	,	O	O
RORY	RORY	NNP	B-NP	O
S.	S.	NNP	I-NP	O
487-89-16-7	487-89-16-7	CD	I-NP	O
NH	NH	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
11/29/05	11/29/05	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
CONTINGENT	CONTINGENT	JJ	B-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FLINNER	FLINNER	NN	B-NP	O
,	,	,	O	O
FEDERICO	FEDERICO	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
by	by	IN	B-PP	O
BESHAW	BESHAW	NNP	B-NP	O
,	,	,	O	O
KORY	KORY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
90622191	90622191	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
by	by	IN	B-PP	O
ACCALA	ACCALA	NNP	B-NP	O
,	,	,	O	O
FERDINAND	FERDINAND	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
90622191	90622191	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
KLONOPIN	KLONOPIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLONAZEPAM	CLONAZEPAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
,	,	,	O	O
Anxiety	Anxiety	NNP	B-NP	O
COLCHICINE	COLCHICINE	NNP	I-NP	O
0.3	0.3	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
by	by	IN	B-PP	O
DIX	DIX	NNP	B-NP	O
,	,	,	O	O
EDDY	EDDY	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
RAPAMYCIN	RAPAMYCIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
11112385	11112385	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
COLCHICINE	COLCHICINE	NNP	B-NP	O
&	&	CC	I-NP	O
SIROLIMUS	SIROLIMUS	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
COLCHICINE	COLCHICINE	NNP	B-NP	O
&	&	CC	I-NP	O
SIROLIMUS	SIROLIMUS	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
-	-	HYPH	B-ADVP	O
on	on	RB	B-PP	O
as	as	IN	B-PP	O
stable	stable	JJ	B-NP	O
home	home	NN	I-NP	O
med	me	VBN	B-VP	O
.	.	.	O	O

DOBUTAMINE	DOBUTAMINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
IV	IV	CD	I-NP	O
2	2	CD	I-NP	O
mcg/kg/min	mcg/kg/min	NN	I-NP	O
in	in	IN	B-PP	O
D5W	D5W	NN	B-NP	O
continuous	continuous	JJ	I-NP	O
IV	IV	CD	I-NP	O
HYDRALAZINE	HYDRALAZINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
80	80	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ISORDIL	ISORDIL	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ALDACTONE	ALDACTONE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
by	by	IN	B-PP	O
KEETH	KEETH	NNP	B-NP	O
,	,	,	O	O
MATHEW	MATHEW	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
requires	require	VBZ	B-VP	O
COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QPM	QPM	NN	I-NP	O
Starting	Start	VBG	B-VP	O
NOW	NOW	RB	B-NP	O
-LRB-	-LRB-	JJ	I-NP	O
9/10	9/10	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
WITHIN	WITHIN	NN	B-NP	O
HOUR	HOUR	NN	I-NP	O
OF	OF	IN	B-PP	O
PHARMACY	PHARMACY	NNP	B-NP	O
APPROVAL	APPROVAL	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
by	by	IN	B-PP	O
UNG	UNG	NNP	B-NP	O
,	,	,	O	O
RUBIN	RUBIN	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
by	by	IN	B-PP	O
ARNELL	ARNELL	NNP	B-NP	O
,	,	,	O	O
KERRY	KERRY	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
90622191	90622191	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
K-DUR	K-DUR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
OHMC	OHMC	NNP	B-NP	B-cell_type
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
by	by	IN	B-PP	O
MUSETTI	MUSETTI	NNP	B-NP	O
,	,	,	O	O
ARNULFO	ARNULFO	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALDACTONE	ALDACTONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
55465725	55465725	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
requires	require	VBZ	B-VP	O
TORSEMIDE	TORSEMIDE	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
by	by	IN	B-PP	O
COLAVITO	COLAVITO	NNP	B-NP	O
,	,	,	O	O
IVORY	IVORY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TORSEMIDE	TORSEMIDE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
81304726	81304726	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Rash	Rash	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
CELLCEPT	CELLCEPT	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
MYCOPHENOLATE	MYCOPHENOLATE	NN	I-NP	O
MOFETIL	MOFETIL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food	Food	NNP	I-NP	O
decreases	decrease	VBZ	B-VP	O
peak	peak	NN	B-NP	O
by	by	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
NIFEREX	NIFEREX	NN	I-NP	O
TABLET	TABLET	NN	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
RAPAMYCIN	RAPAMYCIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIROLIMUS	SIROLIMUS	VBZ	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/13/05	9/13/05	CD	B-NP	O
by	by	IN	B-PP	O
BIDDIE	BIDDIE	NNP	B-NP	O
,	,	,	O	O
JOSIAH	JOSIAH	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
COLCHICINE	COLCHICINE	NNP	B-NP	O
&	&	CC	I-NP	O
SIROLIMUS	SIROLIMUS	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
COLCHICINE	COLCHICINE	NNP	B-NP	O
&	&	CC	I-NP	O
SIROLIMUS	SIROLIMUS	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
-	-	HYPH	B-ADVP	O
on	on	RB	B-PP	O
as	as	IN	B-PP	O
stable	stable	JJ	B-NP	O
home	home	NN	I-NP	O
med	me	VBN	B-VP	O
.	.	.	O	O

NEXIUM	NEXIUM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
HMC	HMC	NNP	I-NP	B-cell_type
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
Service	Service	NNP	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
4/16/05	4/16/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
4-7	4-7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
CMH	CMH	NN	B-NP	O
Anticoagulation	Anticoagulation	NN	I-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
SUCCINYLCHOLINE	SUCCINYLCHOLINE	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
Morphine	Morphine	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Atrial	Atrial	JJ	B-NP	O
fibrilation	fibrilation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Atrial	Atrial	NNP	I-NP	O
fibrilation	fibrilation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
s/p	s/p	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
htn	htn	NN	I-NP	O
obesity	obesity	NN	I-NP	O
CRI	CRI	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
ccy	ccy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pulm	pulm	NN	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
toxicity	toxicity	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
,	,	,	O	O
Management	Management	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
33-year-old	33-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
and	and	CC	O	O
declining	decline	VBG	B-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
from	from	IN	B-PP	O
Heart	Heart	NNP	B-NP	O
Failure	Failure	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
after	after	IN	B-PP	O
presenting	present	VBG	B-VP	O
for	for	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
eval	eval	NN	B-NP	O
and	and	CC	O	O
noted	note	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
new	new	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
VR	VR	NN	B-NP	B-protein
of	of	IN	B-PP	O
130	130	CD	B-NP	O
.	.	.	O	O

Mrs.	Mrs.	NNP	B-NP	O
Kiyuna	Kiyuna	NNP	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
admission	admission	NN	I-NP	O
requiring	require	VBG	B-VP	O
IV	IV	CD	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
pressor	pressor	NN	B-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
2mcg/kg/min	2mcg/kg/min	NN	I-NP	O
and	and	CC	O	O
PO	PO	NN	B-NP	O
torsamide	torsamide	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
intervening	intervening	JJ	I-NP	O
period	period	NN	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
feeling	feel	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
quite	quite	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
dizziness	dizziness	NN	I-NP	O
/	/	SYM	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
syncope	syncope	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
any	any	DT	B-NP	O
feeling	feeling	NN	I-NP	O
of	of	IN	B-PP	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
F/C/NS	F/C/NS	NN	I-NP	B-protein
.	.	.	O	O

Change	Change	NN	B-NP	O
in	in	IN	B-PP	O
wt	wt	NN	B-NP	O
.	.	.	O	O

+	+	SYM	O	O
LE	LE	NN	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
.	.	.	O	O

Orthopnea	Orthopnea	NNP	B-NP	O
PND	PND	NNP	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
URI	URI	NN	I-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
bowel	bowel	NN	B-NP	O
habits	habit	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
urgency	urgency	NN	I-NP	O
,	,	,	I-NP	O
dysuria	dysuria	NN	I-NP	O
or	or	CC	I-NP	O
frequency	frequency	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
nocturia	nocturia	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
arthralgias	arthralgia	NNS	I-NP	O
or	or	CC	I-NP	O
myalgias	myalgia	NNS	I-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Dilated	Dilate	VBN	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
1989	1989	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Episode	Episode	NN	B-NP	O
of	of	IN	B-PP	O
rejection	rejection	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
graft	graft	NN	I-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Deterioration	Deterioration	NN	B-NP	O
of	of	IN	B-PP	O
LV	LV	NN	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
annual	annual	JJ	B-NP	O
surveillance	surveillance	NN	I-NP	O
,	,	,	O	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
cath	cath	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
stented	stente	VBN	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Prior	Prior	JJ	B-NP	O
admission	admission	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
esophagitis	esophagitis	NN	B-NP	O
believed	believe	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
immediate-release	immediate-release	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

SVT	SVT	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Gout	Gout	NNP	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

MEDS	MEDS	NNS	B-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
on	on	IN	B-PP	O
D/C	D/C	NN	B-NP	B-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.3	0.3	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dobutamine	Dobutamine	NN	B-NP	O
IV	IV	CD	I-NP	O
drip	drip	NN	I-NP	O
2	2	CD	B-NP	O
mcg/kg/min	mcg/kg/min	NN	I-NP	O
5	5	CD	B-NP	O
.	.	.	O	O

Pepcid	Pepcid	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
twice	twice	RB	B-NP	O
daily	daily	RB	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Aldactone	Aldactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

CellCept	CellCept	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Niferex	Niferex	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
325-650	325-650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Clonopin	Clonopin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Rapamycin	Rapamycin	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
-	-	HYPH	B-NP	O
hives	hive	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
contrast	contrast	NN	B-NP	O
when	when	WRB	B-ADVP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Benadryl	Benadryl	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

Sulfa	Sulfa	NN	B-NP	O
-	-	HYPH	I-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
married	marry	VBN	I-VP	O
and	and	CC	O	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
and	and	CC	I-NP	O
4	4	CD	I-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
ethanol	ethanol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Mother	Mother	NNP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
Crohn	Crohn	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

EXAM	EXAM	NN	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T97	T97	NN	B-NP	B-protein
,	,	,	O	O
P128	P128	NN	B-NP	B-protein
,	,	,	O	O
BP120/20	BP120/20	NN	B-NP	B-protein
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
18	18	CD	I-NP	I-protein
,	,	,	O	O
98	98	CD	B-NP	O
O2Sat	O2Sat	NNP	I-NP	O
RA	RA	NNP	I-NP	O
Gen	Gen	NNP	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
Alert	Alert	NNP	B-NP	O
,	,	,	O	O
NAD	NAD	NNP	B-NP	O
HEENT	HEENT	NNP	I-NP	O
:	:	:	O	O
Anicteric	Anicteric	NNP	B-NP	O
,	,	,	O	O
PERRLA	PERRLA	NNP	B-NP	O
,	,	,	O	O
EOMI	EOMI	NNP	B-NP	O
,	,	,	O	O
MMM	MMM	NNP	B-NP	O
,	,	,	O	O
OP	OP	NNP	B-NP	O
Clear	Clear	NNP	I-NP	O
Neck	Neck	NNP	I-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	O
approx	approx	NN	I-NP	O
10cm	10cm	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
Tachycardic	Tachycardic	JJ	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
,	,	,	I-NP	O
Nml	Nml	NN	I-NP	B-protein
s1s2	s1s2	NN	I-NP	I-protein
,	,	,	O	O
Prominent	Prominent	JJ	B-NP	O
gallop	gallop	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
termine	termine	VB	I-VP	O
s3	s3	NN	B-NP	B-protein
vs	vs	IN	B-PP	O
s4	s4	NN	B-NP	O
given	give	VBN	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	B-protein
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
BS	BS	NNP	B-NP	O
at	at	IN	B-PP	O
RLB	RLB	NNP	B-NP	O
Abd	Abd	NNP	I-NP	O
:	:	:	O	O
Obese	Obese	NNP	B-NP	O
,	,	,	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
NT/ND	NT/ND	NNP	B-NP	O
No	No	NNP	I-NP	O
HSM	HSM	NN	I-NP	O
or	or	CC	I-NP	O
mass	mass	NN	I-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

+	+	SYM	O	O
striea	striea	NN	B-NP	O
and	and	CC	I-NP	O
echymosis	echymosis	NN	I-NP	O
.	.	.	O	O

Ext	Ext	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
C/C	C/C	NN	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Edema	Edema	NNP	I-NP	O
,	,	,	O	O
DP	DP	NNP	B-NP	O
pulses	pulse	VBZ	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
Bilat	Bilat	NN	I-NP	O
Neuro	Neuro	NNP	I-NP	O
:	:	:	O	O
Grossly	Grossly	NNP	B-NP	O
Nml	Nml	NNP	I-NP	O
.	.	.	O	O

LABS	LABS	NNP	B-NP	O
:	:	:	O	O
Pending	Pending	NNP	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	O
:	:	:	O	O
AFIB	AFIB	NN	B-NP	B-protein
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
138	138	CD	I-NP	O
,	,	,	I-NP	O
RBB	RBB	NN	I-NP	B-protein
and	and	CC	I-NP	O
LAFB	LAFB	NN	I-NP	B-protein
.	.	.	O	O

1/28/05	1/28/05	CD	B-NP	O
,	,	,	O	O
echo	echo	NN	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
TR	TR	NN	I-NP	O
and	and	CC	I-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
PIT	PIT	NN	B-NP	B-protein
estimated	estimate	VBD	B-VP	O
11	11	CD	B-NP	O
.	.	.	O	O

8/30/05	8/30/05	CD	B-NP	O
,	,	,	O	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dobutamine	dobutamine	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
wall	wall	NN	B-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

10/10/05	10/10/05	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
-	-	HYPH	B-VP	O
left	leave	VBN	B-NP	O
main	main	JJ	I-NP	O
,	,	,	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

RA	RA	NN	B-NP	B-protein
22	22	CD	I-NP	I-protein
,	,	,	O	O
PCW	PCW	NN	B-NP	O
25	25	CD	I-NP	O
with	with	IN	B-PP	O
V	V	NN	B-NP	B-protein
waves	wave	NNS	I-NP	I-protein
-	-	SYM	O	I-protein
35	35	CD	B-NP	I-protein
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
Mrs	Mrs	NNP	B-NP	B-protein
Quander	Quander	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
33	33	CD	I-NP	O
F	F	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
1989	1989	CD	I-NP	O
with	with	IN	B-PP	O
allograft	allograft	NN	B-NP	O
CAD	CAD	NN	I-NP	O
and	and	CC	O	O
declining	decline	VBG	B-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
ionotropic	ionotropic	JJ	B-NP	O
support	support	NN	I-NP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
new	new	JJ	B-NP	O
A	A	NNP	I-NP	O
Fib	Fib	NNP	I-NP	B-protein
.	.	.	O	O

Given	Give	VBN	B-NP	O
tenuous	tenuous	JJ	I-NP	O
function	function	NN	I-NP	O
A	A	NN	I-NP	O
Fib	Fib	NN	I-NP	O
likely	likely	RB	B-ADVP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
poorly	poorly	RB	B-ADJP	O
tolerated	tolerate	VBN	I-ADJP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CV	CV	NNP	I-NP	O
a.	a.	FW	I-NP	O
Isch	Isch	NNP	I-NP	O
-	-	HYPH	B-NP	O
Cont	Cont	NNP	I-NP	O
.	.	.	O	O

ASA	ASA	NN	B-NP	O
,	,	,	O	O
Statin	Statin	NN	B-NP	B-protein
,	,	,	O	O
hydral	hydral	JJ	B-NP	O
and	and	CC	I-NP	O
nitrate	nitrate	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

b.	b.	LS	B-NP	O
Pump	Pump	NNP	I-NP	O
-	-	HYPH	I-NP	O
Cont	Cont	NNP	I-NP	O
dobutamine	dobutamine	NN	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
MCG/KG/MIN	MCG/KG/MIN	NN	I-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
PO	PO	NNP	I-NP	O
torsamide	torsamide	NN	I-NP	O
c.	c.	NN	I-NP	O
Rhyth	Rhyth	NN	I-NP	O
-	-	HYPH	B-ADVP	O
On	On	IN	B-PP	O
tele	tele	NN	B-NP	O
-	-	HYPH	B-ADJP	O
with	with	IN	B-PP	O
AF	AF	NN	B-NP	B-protein
.	.	.	O	O

Goal	Goal	NN	B-NP	O
to	to	TO	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
underlying	underlie	VBG	B-VP	O
hypotention	hypotention	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
limiting	limit	VBG	I-VP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
start	start	VB	I-VP	O
Heparin	Heparin	NN	B-NP	O
for	for	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
50-70	50-70	CD	I-NP	O
PTT	PTT	NN	I-NP	O
.	.	.	O	O

EP	EP	NN	B-NP	B-protein
consulted	consult	VBD	B-VP	O
re	re	NN	B-NP	O
:	:	:	O	O
rhythem	rhythem	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
past	past	JJ	I-NP	O
Amiodarone	Amiodarone	NN	I-NP	O
toxicity	toxicity	NN	I-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
antiarhythmic	antiarhythmic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
benifit	benifit	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
anticoagulate	anticoagulate	VB	I-VP	O
and	and	CC	O	O
send	send	VB	B-VP	O
out	out	RP	B-PRT	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sachse	Sachse	NNP	I-NP	O
in	in	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Pulm	Pulm	NNP	I-NP	O
-	-	HYPH	I-NP	O
Will	Will	NNP	I-NP	O
check	check	NN	I-NP	O
CXR	CXR	NN	I-NP	O
for	for	IN	B-PP	O
pulm	pulm	NN	B-NP	O
process	process	NN	I-NP	O
as	as	IN	B-PP	O
inciting	incite	VBG	B-VP	O
cause	cause	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
negative	negative	JJ	I-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Renal	Renal	JJ	I-NP	O
-	-	HYPH	I-NP	O
Baseline	Baseline	NN	I-NP	O
CRI	CRI	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
follow	follow	VBP	B-VP	O
closely	closely	RB	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ID	ID	NN	I-NP	B-protein
-	-	HYPH	O	O
No	No	DT	B-NP	O
issues	issue	NNS	I-NP	O
5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Rheum	Rheum	NN	I-NP	O
-	-	HYPH	B-NP	O
H/O	H/O	NN	I-NP	O
gout	gout	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
cont	cont	VB	I-VP	O
allopurinol	allopurinol	NN	B-NP	O
and	and	CC	I-NP	O
Colchacine	Colchacine	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
GI	GI	NN	I-NP	O
-	-	HYPH	I-NP	O
H/O	H/O	NN	I-NP	O
esophagitis	esophagitis	NN	I-NP	O
.	.	.	O	O

NO	NO	NN	B-NP	O
IR	IR	NN	I-NP	O
KCL	KCL	NN	I-NP	O
.	.	.	O	O

Cont	Cont	NN	B-NP	O
pepcid	pepcid	NN	I-NP	O
and	and	CC	I-NP	O
nexium	nexium	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Immune	Immune	NNP	I-NP	O
-	-	HYPH	O	O
Cont	Cont	NNP	B-NP	O
Cellcept	Cellcept	NNP	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	I-NP	O
rapamycin	rapamycin	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
check	check	VB	I-VP	O
rapa	rapa	NN	B-NP	O
level	level	NN	I-NP	O
give	give	VBP	B-VP	O
past	past	JJ	B-NP	O
high	high	JJ	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
start	start	VB	I-VP	O
transplant	transplant	NN	B-NP	O
eval	eval	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Heme	Heme	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Heparin	Heparin	NN	I-NP	O
for	for	IN	B-PP	O
new	new	JJ	B-NP	O
Afib	Afib	NNP	I-NP	O
.	.	.	O	O

Goal	Goal	NNP	B-NP	O
50-70	50-70	CD	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
start	start	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
and	and	CC	O	O
get	get	VB	B-VP	O
to	to	TO	B-PP	O
goal	goal	JJ	B-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2.0	2.0	CD	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Endo	Endo	NNP	I-NP	O
-	-	HYPH	I-NP	O
Will	Will	NNP	I-NP	O
check	check	NN	I-NP	O
TSH	TSH	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
returned	return	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Neuro/Psych	Neuro/Psych	NNP	I-NP	O
-	-	HYPH	I-NP	O
Cont	Cont	NNP	I-NP	O
clonapin	clonapin	NN	I-NP	O
1	1	CD	I-NP	O
PRN	PRN	NN	I-NP	O
11	11	CD	I-NP	O
-RRB-	-RRB-	:	O	O
PPX	PPX	NN	B-NP	B-protein
-	-	HYPH	B-ADJP	O
On	On	IN	B-PP	O
heparin	heparin	NN	B-NP	O
and	and	CC	O	O
PPI	PPI	NN	B-NP	O
12	12	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
FULL	FULL	NN	I-NP	O
CODE	CODE	NN	I-NP	O
Discharged	Discharge	VBD	B-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
on	on	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
as	as	IN	B-PP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
on	on	IN	I-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
new	new	JJ	B-NP	O
PAF	PAF	NN	I-NP	B-protein
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
discontinuation	discontinuation	NN	I-NP	O
of	of	IN	B-PP	O
you	you	PRP	B-NP	O
dobutamine	dobutamine	VBP	B-VP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
reason	reason	NN	I-NP	O
please	please	NN	B-NP	O
contact	contact	VB	B-VP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrilation	fibrilation	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
draws	draw	NNS	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
notice	notice	VBP	B-VP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
or	or	CC	O	O
increased	increase	VBN	B-NP	O
SOB	SOB	NN	I-NP	O
contact	contact	NN	I-NP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
worsening	worsen	VBG	I-VP	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
or	or	CC	O	O
lightheadedness	lightheadedness	NN	B-NP	O
please	please	NN	I-NP	O
seek	seek	VBP	B-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
blood	blood	NN	B-NP	O
draws	draw	NNS	I-NP	O
starting	start	VBG	B-VP	O
4/16/05	4/16/05	CD	B-NP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
now	now	RB	B-ADVP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
taking	take	VBG	I-VP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
VNA	VNA	NN	I-NP	O
service	service	NN	I-NP	O
call	call	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
results	result	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
DHMC	DHMC	NNP	I-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
915-360-5305	915-360-5305	CD	B-NP	O
.	.	.	O	O

Alternatively	Alternatively	RB	B-ADVP	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
faxed	fax	VBN	I-VP	O
to	to	TO	B-PP	O
345-082-4343	345-082-4343	CD	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
later	later	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
same	same	JJ	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
or	or	CC	O	O
following	follow	VBG	B-NP	O
day	day	NN	I-NP	O
if	if	IN	B-SBAR	O
results	result	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
late	late	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ADRIANO	ADRIANO	NNP	B-NP	O
,	,	,	O	O
CHONG	CHONG	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TK920	TK920	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/29/05	11/29/05	CD	I-NP	O
@	@	SYM	B-NP	O
07	07	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

